
Rei Tsang Shiao
Examiner (ID: 18982, Phone: (571)272-0707 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1629, 1628, 1691, 1626 |
| Total Applications | 3089 |
| Issued Applications | 2218 |
| Pending Applications | 222 |
| Abandoned Applications | 691 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15324063
[patent_doc_number] => 20200002361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/570065
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16570065
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/570065 | Boronate ester compounds and pharmaceutical compositions thereof | Sep 12, 2019 | Issued |
Array
(
[id] => 15708631
[patent_doc_number] => 20200101081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => COMBINATION THERAPY FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/562683
[patent_app_country] => US
[patent_app_date] => 2019-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16562683
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/562683 | Combination therapy for treating cancer | Sep 5, 2019 | Issued |
Array
(
[id] => 15239357
[patent_doc_number] => 20190374464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE
[patent_app_type] => utility
[patent_app_number] => 16/549838
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16549838
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/549838 | Intranasal pharmaceutical dosage forms comprising naloxone | Aug 22, 2019 | Issued |
Array
(
[id] => 15321193
[patent_doc_number] => 20200000926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTIONING AND/OR ENDOSCOPIC SUBMUCOSAL DISSECTION
[patent_app_type] => utility
[patent_app_number] => 16/536572
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16536572
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/536572 | Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection | Aug 8, 2019 | Issued |
Array
(
[id] => 15405203
[patent_doc_number] => 20200022923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => INHIBITION OF RESPIRATORY COMPLEX III BY LIGANDS THAT INTERACT WITH A REGULATORY SWITCH
[patent_app_type] => utility
[patent_app_number] => 16/531511
[patent_app_country] => US
[patent_app_date] => 2019-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16531511
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/531511 | Inhibition of respiratory complex III by ligands that interact with a regulatory switch | Aug 4, 2019 | Issued |
Array
(
[id] => 16189227
[patent_doc_number] => 20200230076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => COMPOSITIONS COMPRISING A DENDRIMER-RESVERATROL COMPLEX AND METHODS FOR MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/522459
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20100
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16522459
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/522459 | Compositions comprising a dendrimer-resveratrol complex and methods for making and using the same | Jul 24, 2019 | Issued |
Array
(
[id] => 15114259
[patent_doc_number] => 20190343762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => INJECTION SOLUTION COMPRISING A NON-NUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR AND POLY(LACTIDE-CO-GLYCOLIDE)
[patent_app_type] => utility
[patent_app_number] => 16/521760
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16521760
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/521760 | INJECTION SOLUTION COMPRISING A NON-NUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR AND POLY(LACTIDE-CO-GLYCOLIDE) | Jul 24, 2019 | Abandoned |
Array
(
[id] => 17774901
[patent_doc_number] => 20220241250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => LIQUID TOPICAL PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/262573
[patent_app_country] => US
[patent_app_date] => 2019-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/262573 | LIQUID TOPICAL PREPARATION | Jul 23, 2019 | Abandoned |
Array
(
[id] => 15038481
[patent_doc_number] => 20190330245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => Boron-Containing Small Molecules
[patent_app_type] => utility
[patent_app_number] => 16/510135
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16510135
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/510135 | Boron-Containing Small Molecules | Jul 11, 2019 | Abandoned |
Array
(
[id] => 16563211
[patent_doc_number] => 10888558
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Regimens of tafenoquine for prevention of malaria in malaria-naive subjects
[patent_app_type] => utility
[patent_app_number] => 16/504533
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20534
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16504533
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/504533 | Regimens of tafenoquine for prevention of malaria in malaria-naive subjects | Jul 7, 2019 | Issued |
Array
(
[id] => 19622949
[patent_doc_number] => 12161741
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Skin gel preparation for external use
[patent_app_type] => utility
[patent_app_number] => 17/260821
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3460
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260821
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/260821 | Skin gel preparation for external use | Jul 7, 2019 | Issued |
Array
(
[id] => 19793291
[patent_doc_number] => 12234220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Immunomodulatory compounds
[patent_app_type] => utility
[patent_app_number] => 17/255738
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 24161
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255738
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255738 | Immunomodulatory compounds | Jun 26, 2019 | Issued |
Array
(
[id] => 15290523
[patent_doc_number] => 20190388397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/448439
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448439
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448439 | Compositions and methods for the treatment and prevention of neurological disorders | Jun 20, 2019 | Issued |
Array
(
[id] => 15360677
[patent_doc_number] => 20200016103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => COMPOSITIONS AND METHODS TO MODULATE CHLORIDE ION CHANNEL ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/449021
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16449021
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/449021 | Compositions and methods to modulate chloride ion channel activity | Jun 20, 2019 | Issued |
Array
(
[id] => 14960505
[patent_doc_number] => 20190307730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => COMPOUNDS AND METHODS FOR TREATING INFLUENZA
[patent_app_type] => utility
[patent_app_number] => 16/448267
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448267
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448267 | Compounds and methods for treating influenza | Jun 20, 2019 | Issued |
Array
(
[id] => 15694295
[patent_doc_number] => 10603308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-31
[patent_title] => Methods and compositions for treatment of epileptic disorders
[patent_app_type] => utility
[patent_app_number] => 16/447300
[patent_app_country] => US
[patent_app_date] => 2019-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 20328
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16447300
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/447300 | Methods and compositions for treatment of epileptic disorders | Jun 19, 2019 | Issued |
Array
(
[id] => 14893719
[patent_doc_number] => 20190290625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => METHOD OF TREATMENT WITH TRADIPITANT
[patent_app_type] => utility
[patent_app_number] => 16/430514
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16430514
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/430514 | Method of treatment with tradipitant | Jun 3, 2019 | Issued |
Array
(
[id] => 16589242
[patent_doc_number] => 10898484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Method of reducing pulmonary exacerbations in respiratory disease patients
[patent_app_type] => utility
[patent_app_number] => 16/427571
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 37
[patent_no_of_words] => 22085
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427571
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/427571 | Method of reducing pulmonary exacerbations in respiratory disease patients | May 30, 2019 | Issued |
Array
(
[id] => 19291521
[patent_doc_number] => 12030867
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Hsp90b selective inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/055980
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 19538
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055980
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055980 | Hsp90b selective inhibitors | May 29, 2019 | Issued |
Array
(
[id] => 16710301
[patent_doc_number] => 20210077448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => Agent for Preventing or Amelioriting Noctura
[patent_app_type] => utility
[patent_app_number] => 16/975184
[patent_app_country] => US
[patent_app_date] => 2019-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975184
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/975184 | Agent for preventing or amelioriting nocturia | May 26, 2019 | Issued |